Emma Watts
Parkville, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Cost-effectiveness and budget impact analyses of introducing typhoid conjugate vaccine into Indonesia's national immunisation program.
Journal: Vaccine
Published: May 13, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.
Journal: The Journal of infection
Published: November 11, 2025
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial.
Journal: Nature communications
Published: May 06, 2025
Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study.
Journal: PLoS medicine
Published: April 06, 2025
The efficacy of a single dose of oral azithromycin in labour to prevent infections in infants and birthing parents in Fiji: secondary outcomes from a randomised controlled trial.
Journal: BMJ global health
Published: April 03, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.
Journal: The Journal of infection
Published: November 07, 2024
Environmental surveillance for Salmonella Typhi to detect the typhoid burden in Yogyakarta, Indonesia.
Journal: International journal of hygiene and environmental health
Published: October 22, 2024
The safety and efficacy of a single dose of oral azithromycin given in labour to prevent skin and soft tissue infections in young infants in Fiji: a randomised controlled trial.
Journal: BMC medicine
Published: October 11, 2024
Cost effectiveness analysis of rotavirus vaccination in Indonesia.
Journal: Vaccine
Published: May 07, 2024
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BB.
Journal: Nature communications
Published: May 02, 2024
Last Updated: 09/26/2026